Human intraepithelial mast cell differentiation and effector function are directed by TGF-β signaling
Authors:
- Tahereh DerakhshanTDTahereh Derakhshan
- Eleanor HollersEHEleanor Hollers
- Alex PernissAPAlex Perniss
- Tessa RyanTRTessa Ryan
- Alanna McGillAMAlanna McGill
- Jonathan HackerJHJonathan Hacker
- Regan W. BergmarkRBRegan W. Bergmark
- Neil BhattacharyyaNBNeil Bhattacharyya
- Stella E. LeeSLStella E. Lee
- Alice Z. MaxfieldAMAlice Z. Maxfield
- Rachel E. RoditiRRRachel E. Roditi
- Lora BankovaLBLora Bankova
Open Access
- 2 January 2025
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (1)
Abstract
Mast cells (MCs) expressing a distinctive protease phenotype (MC T s) selectively expand within the epithelium of human mucosal tissues during type 2 (T2) inflammation. While MC T s are phenotypically distinct from subepithelial MCs (MC TC s), signals driving human MC T differentiation and this subset’s contribution to inflammation remain unexplored. Here, we have identified TGF-β as a key driver of the MC T transcriptome in nasal polyps. We found that short-term TGF-β signaling alters MC cell surface receptor expression and partially recapitulated the in vivo MC T transcriptome, while TGF-β signaling during MC differentiation upregulated a larger number of MC T -associated transcripts. TGF-β inhibited the hallmark MC TC proteases chymase and cathepsin G at both the transcript and protein level, allowing selective in vitro differentiation of MC T s for functional study. We identified discrete differences in effector phenotype between in vitro–derived MC T s and MC TC s, with MC T s exhibiting enhanced proinflammatory lipid mediator generation and a distinct cytokine, chemokine, and growth factor production profile in response to both innate and adaptive stimuli, recapitulating functional features of their tissue-associated counterpart MC subsets. Thus, our findings support a role for TGF-β in promoting human MC T differentiation and identified a discrete contribution of this cell type to T2 inflammation.Keywords
Funding Information
- National Institutes of Health (AI078908,R37AI052353,R01AI136041,R01AI130109,R01AI175149,U19 AI095219,K22 AI146281)
- Brigham and Women's Hospital (Hearst Young Investigator Award)
This publication has 65 references indexed in Scilit:
- Abnormal mast cells in mice deficient in a heparin-synthesizing enzymeNature, 1999
- Transforming Growth Factor β1 and Recruitment of Macrophages and Mast Cells in Airways in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation.1998
- Mast cellsPhysiological Reviews, 1997
- Transforming Growth Factor- β 1 in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Heterogeneity of human mast cells based on cytokine contentThe Journal of Immunology, 1995
- Expression of the β6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodelingJournal of Cell Science, 1995
- Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthmaJournal of Allergy and Clinical Immunology, 1994
- Immunohistology of the nasal mucosa in seasonal allergic rhinitis: Increases in activated eosinophils and epithelial mast cellsJournal of Allergy and Clinical Immunology, 1992
- Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.Proceedings of the National Academy of Sciences, 1987